Heparanase pretreatment attenuates endotoxin-induced acute lung injury in rats. 2007

Yulia Bashenko, and Neta Ilan, and Michael M Krausz, and Israel Vlodavsky, and Mark I Hirsh
Cancer and Vascular Biology Research Center, Technion-Israel Institute of Technology, Haifa, Israel.

A central event of systemic inflammation and septic organ injury is infiltration of tissues with polymorphonuclear neutrophils, likely modulated by the integrity of the extracellular matrix underlying the vascular endothelium. In the present study, the effect of matrix-modifying endoglycosidase (heparanase) on endotoxin (LPS)-induced inflammatory lung injury was investigated in rats. Animals were treated with heparanase or LPS or pretreated with heparanase before LPS injection, and acute lung injury was verified histologically and characterized by analysis of bronchoalveolar lavage fluids. Pretreatment with heparanase attenuated the mortality of animals and preserved the histological structure of the lungs. Furthermore, polymorphonuclear neutrophil accumulation and activation, analyzed by myeloperoxidase release and reactive oxygen species production associated with lung injury, were significantly reduced upon heparanase pretreatment. In addition, heparanase pretreatment elevated the IL-10 levels in the pulmonary compartment. Moreover, results from in vitro experiments have identified monocyte-derived IL-10 as an important mediator used by heparanase to suppress inflammatory reactions. The protective effect of heparanase may indicate a novel therapeutic strategy for sepsis.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D012128 Respiratory Distress Syndrome A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA. ARDS, Human,Acute Respiratory Distress Syndrome,Adult Respiratory Distress Syndrome,Pediatric Respiratory Distress Syndrome,Respiratory Distress Syndrome, Acute,Respiratory Distress Syndrome, Adult,Respiratory Distress Syndrome, Pediatric,Shock Lung,Distress Syndrome, Respiratory,Distress Syndromes, Respiratory,Human ARDS,Lung, Shock,Respiratory Distress Syndromes,Syndrome, Respiratory Distress
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D004731 Endotoxins Toxins closely associated with the living cytoplasm or cell wall of certain microorganisms, which do not readily diffuse into the culture medium, but are released upon lysis of the cells. Endotoxin
D005966 Glucuronidase Endo-beta-D-Glucuronidase,Endoglucuronidase,Exo-beta-D-Glucuronidase,beta-Glucuronidase,Endo beta D Glucuronidase,Exo beta D Glucuronidase,beta Glucuronidase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Yulia Bashenko, and Neta Ilan, and Michael M Krausz, and Israel Vlodavsky, and Mark I Hirsh
March 2006, Critical care medicine,
Yulia Bashenko, and Neta Ilan, and Michael M Krausz, and Israel Vlodavsky, and Mark I Hirsh
January 2006, The American journal of Chinese medicine,
Yulia Bashenko, and Neta Ilan, and Michael M Krausz, and Israel Vlodavsky, and Mark I Hirsh
February 2016, Inflammation,
Yulia Bashenko, and Neta Ilan, and Michael M Krausz, and Israel Vlodavsky, and Mark I Hirsh
June 1999, The Journal of surgical research,
Yulia Bashenko, and Neta Ilan, and Michael M Krausz, and Israel Vlodavsky, and Mark I Hirsh
January 2004, American journal of respiratory and critical care medicine,
Yulia Bashenko, and Neta Ilan, and Michael M Krausz, and Israel Vlodavsky, and Mark I Hirsh
November 2005, Annals of the New York Academy of Sciences,
Yulia Bashenko, and Neta Ilan, and Michael M Krausz, and Israel Vlodavsky, and Mark I Hirsh
November 1997, American journal of respiratory cell and molecular biology,
Yulia Bashenko, and Neta Ilan, and Michael M Krausz, and Israel Vlodavsky, and Mark I Hirsh
September 2023, American journal of physiology. Lung cellular and molecular physiology,
Yulia Bashenko, and Neta Ilan, and Michael M Krausz, and Israel Vlodavsky, and Mark I Hirsh
May 1998, Critical care medicine,
Yulia Bashenko, and Neta Ilan, and Michael M Krausz, and Israel Vlodavsky, and Mark I Hirsh
January 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Copied contents to your clipboard!